文献
J-GLOBAL ID:202202211476321820
整理番号:22A0669345
MiR-182-5pはUBE2Tを抑制して腎明細胞癌の腫瘍形成を抑制
MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T
著者 (38件):
Wu Yucai
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Wu Yucai
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Wu Yucai
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Wu Yucai
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhang Cuijian
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhang Cuijian
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Peng Ding
(Department of Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, People’s Republic of China)
,
He Shiming
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
He Shiming
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
He Shiming
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
He Shiming
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Huang Cong
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Huang Cong
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Huang Cong
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Huang Cong
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Qian Jinqin
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Qian Jinqin
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Qian Jinqin
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Qian Jinqin
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhu Weijie
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhu Weijie
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhu Weijie
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhu Weijie
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Feng Ninghan
(Wuxi No 2 People’s Hospital, Jiangsu, People’s Republic of China)
,
Gong Yanqing
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Gong Yanqing
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Gong Yanqing
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Gong Yanqing
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Li Xuesong
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Li Xuesong
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Li Xuesong
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Li Xuesong
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
,
Zhou Liqun
(Department of Urology, Peking University First Hospital, Beijing, People’s Republic of China)
,
Zhou Liqun
(Institute of Urology, Peking University, Beijing, People’s Republic of China)
,
Zhou Liqun
(National Urological Cancer Center, Beijing, People’s Republic of China)
,
Zhou Liqun
(Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Peking University, Beijing, People’s Republic of China)
資料名:
Human Cell (Web)
(Human Cell (Web))
巻:
35
号:
2
ページ:
542-556
発行年:
2022年
JST資料番号:
U0492A
ISSN:
1749-0774
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)